STAT+: China moves to restrict foreign biotech acquisitions

Waiting on Isomorphic’s AI ambition, California’s $8.4 billion research measure, and more biotech news Adobe Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. I might have been just as unblinking as Elizabeth during the three hours of “You Can See Everything.” Seats-edge viewing experience. What did you think? Also: We’ll be in Madrid later this week for the European Society for Medical Oncology’s annual meeting, and we’ll be penning an ESMO in 30 Seconds newsletter. Sign up here. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.